Creo Medical Group Stock Current Valuation
| CREO Stock | 16.00 0.13 0.81% |
Valuation analysis of Creo Medical Group helps investors to measure Creo Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Creo Medical's Cash And Short Term Investments are comparatively stable compared to the past year. Begin Period Cash Flow is likely to gain to about 23.8 M in 2024, despite the fact that Change In Cash is likely to grow to (9.6 M). Fundamental drivers impacting Creo Medical's valuation include:
Price Book 1.4021 | Enterprise Value 70.9 M | Enterprise Value Ebitda (2.27) | Price Sales 2.2438 | Enterprise Value Revenue 2.3386 |
Overvalued
Today
Please note that Creo Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Creo Medical Group is based on 3 months time horizon. Increasing Creo Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Creo stock is determined by what a typical buyer is willing to pay for full or partial control of Creo Medical Group. Since Creo Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Creo Stock. However, Creo Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.0 | Real 14.88 | Hype 17.17 | Naive 16.33 |
The intrinsic value of Creo Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Creo Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Creo Medical Group helps investors to forecast how Creo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Creo Medical more accurately as focusing exclusively on Creo Medical's fundamentals will not take into account other important factors: Creo Medical Group Company Current Valuation Analysis
Creo Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Creo Medical Current Valuation | 70.86 M |
Most of Creo Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Creo Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Creo Medical Group has a Current Valuation of 70.86 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United Kingdom stocks is notably lower than that of the firm.
Creo Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Creo Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Creo Medical could also be used in its relative valuation, which is a method of valuing Creo Medical by comparing valuation metrics of similar companies.Creo Medical is currently under evaluation in current valuation category among its peers.
Creo Fundamentals
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.89) % | ||||
| Current Valuation | 70.86 M | ||||
| Shares Outstanding | 412.15 M | ||||
| Shares Owned By Insiders | 20.44 % | ||||
| Shares Owned By Institutions | 48.82 % | ||||
| Price To Book | 1.40 X | ||||
| Price To Sales | 2.24 X | ||||
| Revenue | 30.8 M | ||||
| Gross Profit | 11.59 M | ||||
| EBITDA | (20.7 M) | ||||
| Net Income | (21.7 M) | ||||
| Total Debt | 8.3 M | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (21.6 M) | ||||
| Earnings Per Share | (0.06) X | ||||
| Target Price | 57.5 | ||||
| Number Of Employees | 278 | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 67.99 M | ||||
| Total Asset | 76.6 M | ||||
| Retained Earnings | (144.4 M) | ||||
| Working Capital | 28 M | ||||
| Net Asset | 76.6 M |
About Creo Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Creo Medical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creo Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creo Medical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.